Growth and characterization of LNCaP prostate cancer cell spheroids

Clinical Cancer Research

Volumn 5, Issue 10 SUPPL., 1999, Pages

  Ballangrud, Åse M ^a   Yang, Wei Hong ^a   Dnistrian, Ann ^a   Lampen, Nina M ^a   Sgouros, George ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; PROSTATE SPECIFIC ANTIGEN;

CANCER CELL CULTURE; CELL ADHESION; CELL GROWTH; CELL KINETICS; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CELL VOLUME; CONFERENCE PAPER; CONTROLLED STUDY; DESMOSOME; GROWTH CURVE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; SPHEROID CELL;

BROMODEOXYURIDINE; CELL DIVISION; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0032697613     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Sutherland, R. M. Cell and environment interaction in tumor micro-regions: the multicell spheroid model. Science (Washington DC), 240: 177-184, 1988.
2. Kwok, C. S., Crivici, A., MacGregor, W. D., and Unger, M. W. Optimization of radioimmunotherapy using human malignant melanoma multicell spheroids as a model. Cancer Res., 49: 3276-3281, 1989.
3. 131I-Anticarcinoembryonic antigen therapy of LS 174T human colon adenocarcinoma spheroids. Cancer Res., 49: 3401-3406, 1989.
4. Bardies, M., Thedrez, P., Gestin, J. F., Marcille, B. M., Guerreau, D., Faivre-Chauvet, A., Mahe, M., Sai-Maurel, C., and Chatal, J. E. Use of multicell spheroids of ovarian carcinoma as intraperitoneal radioimmunotherapy model: uptake, retention kinetics and dosimetric evaluation. Int. J. Cancer, 50: 984-991, 1992.
5. Lelievre, S., and Larsen, A. K. Development and characterization of suramin-resistant Chinese hamster fibrosarcoma cells: drug-dependent formation of multicellular spheroids and a greatly enhanced metastatic potential. Cancer Res.. 54: 3993-3997, 1994.
6. Walker, K. A., Murray, T., Hilditch, T. E., Wheldon, T. E., Gregor, A., and Hann, I. M. A tumor spheroid model for antibody-targeted therapy of micrometastases. Br. J. Cancer, 58: 13-16, 1988.
7. Kohno, N., Ohnuma, T., Holland, J. F., and Biller, H. Effects of anticancer agents on the shedding of cells from human multicellular tumor spheroids. Invasion Metastasis, 7: 264-274, 1987.
8. Bjerkvig, R. (ed.). Spheroid Culture in Cancer Research. Boca Raton, FL: CRC Press, 1992.
9. Davies, C. D., Muller, H., Hagen, I., Garseth, M., and Hjelstuen, M. H. Comparison of extracellular matrix in human osteosarcomas and melanomas growing as xenografts, multicellular spheroids, and monolayer cultures. Anticancer Res., 17: 4317-4326, 1997.
10. Essand. M., Nilsson, S., and Carlsson, J. Growth of prostate cells, DU 145, as multicellular spheroids and effects of estramustine. Anticancer Res., 13: 1261-1268, 1993.
11. 2+ signaling and volume regulation in proliferating and quiescent cells from multicelluar spheroids. J. Cell. Physiol., 175: 129-140, 1998.
12. Wartenberg, M., Frey, C., Diedershagen, H., Ritgen, J., Hescheler, J., and Sauer, H. Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids. Int. J. Cancer, 75: 855-863, 1998.
13. Donaldson, J. T., Tucker, J. A., Keane, T. E., Walther, P. J., and Webb. K. S. Characterization of a new model of human prostatic cancer: the multicellular tumor spheroid. Int. J. Cancer. 46: 238-244, 1990.
14. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Ming Chu, T., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983.
15. Van Steenbrugge, G. J., Groen, M., van Dongen, J. W., Bolt, J., van der Korput, H., Trapman, J., Hasenson, M., and Horoszewicz, J. The human prostatic carcinoma cell line LNCaP and its derivatives. Urol. Res., 17: 71-77, 1989.
16. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R., and Heston, W. D. W. Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807-1811, 1994.
17. Yuhas, J. M., Li, A. P., Martinez, A. O., and Landman, A. J. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res., 37: 3639-3643, 1977.
18. Gompertz, B. On the nature of the function expressive of the law of human mortality and on a new model of determining life contingencies. Philos. Trans. R. Soc. Lond-Biol. Sci., 115: 513-585, 1825.
19. Norton, L. A Gompertzian model of human breast cancer growth. Cancer Res., 48: 7067-7071, 1988.
20. Steel, G. G. Growth Kinetics of Tumors. Oxford, United Kingdom: Clarendon Press, 1977.
21. SAAM Institute. SAAM II User Guide. Seattle, WA: University of Washington, 1997.
22. Foster, D. M., Boston, R. C., Jacquez, J. A., and Zech, L. A. (eds.). The SAAM Tutorials: An Introduction to Using Conversational SAAM Version 30. Resource Facility for Kinetic Analysis. Seattle, WA: University of Washington, 1989.
23. Durand, R. E. Cell cycle kinetics in an in vitro tumor model. Cell Tissue Kinet., 9: 403-412, 1976.
24. Olea, N., Villalobos, M., Ruiz de Almodóvar, J. M., and Pedraza, V. MCF-7 breast cancer cells grown as multicellular spheroids in vitro: effect of 17β-estradiol. Int. J. Cancer, 50: 112-117, 1992.
25. Olea, N., Villalobos, M., Nuñez, M. I., Elvira, J., Ruiz de Almodóvar, J. M., and Pedraza, V. Evaluation of the growth rate of MCF-7 breast cancer multicellular spheroids using three mathematical models. Cell Prolif., 27: 213-223, 1994.
26. Yang, W-H., Ballangrud, Å. M., McDevitt, M. R., Finn, R. A., Geerlings, M., Bander, N., Scheinberg, D. A., and Sgouros, G. α Particle emitter therapy of micrometastases: 213Bi-J591 (anti-PSMA) treatment of LNCaP spheroids. Proc. Am. Assoc. Cancer Res., 39: 440, 1998.